Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Bone marrow transplantation for chronic myelogenous leukemia
Helen Enright
, Philip McGlave
Medicine - Hematology, Oncology, Transplant
Research output
:
Contribution to journal
›
Review article
›
peer-review
8
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bone marrow transplantation for chronic myelogenous leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bone Marrow Transplantation
100%
Chronic Myeloid Leukemia
100%
Hematological Malignancies
33%
Disease Control
33%
Improved Outcomes
33%
Hematologic
33%
Tyrosine Kinase Inhibitor
33%
Mechanism of Action
33%
Hydroxyurea
33%
Immunological Response
33%
Disease Course
33%
Autologous Transplantation
33%
Chronic Phase
33%
Residual Disease
33%
Busulfan
33%
Patient Selection
33%
Molecular Methods
33%
Blast Crisis
33%
Accelerated Phase
33%
Allogeneic Bone Marrow Transplantation
33%
Ribozyme
33%
Antisense Oligonucleotides
33%
Conventional Therapy
33%
Interferon Therapy
33%
Autografting
33%
Cytogenetic Response
33%
Mobilized Peripheral Blood Stem Cells
33%
Myelopoiesis
33%
Chronic Myeloid Leukaemia Cells
33%
Medicine and Dentistry
Bone Marrow Transplantation
100%
Chronic Myelogenous Leukemia
100%
Diseases
50%
Immune Response
25%
Autotransplantation
25%
Hydroxyurea
25%
Hematologic Malignancy
25%
Peripheral Blood Stem Cell
25%
Leukemia Cell
25%
Minimal Residual Disease
25%
Allogenic Bone Marrow Transplantation
25%
Antisense Oligonucleotide
25%
Blast Cell Crisis
25%
Tyrosine-Kinase Inhibitor
25%
Interferon
25%
Busulfan
25%
Myelopoiesis
25%
Ribozyme
25%